Friday, October 4, 2013
InterContinental Cleveland
Founders Ballroom C
Cleveland, OH
Presentations included allotted time for Audience Response System (ARS) assisted audience
|
|||
7:00 am - 8:00 am | Registration | ||
7:00 am - 8:00 am | Continental Breakfast | ||
8:00 am - 8:10 am | Welcome and Introductions | ||
8:10 am - 8:35 am | Immunology 101 for the Practicing Oncologist Charles Tannenbaum, PhD – Cleveland Clinic |
||
8:35 am - 9:00 am | What You Need to Know about Innate Immunity Jennifer S. Ko, MD, PhD – Cleveland Clinic |
||
9:00 am - 9:25 am | Tumor Microenvironment: Hijacking the Immune System James H. Finke, PhD - Cleveland Clinic |
||
9:25 am - 9:40 am | Break | ||
9:40 am - 10:15 am | Cytokine Therapy: Lessons Learned and Novel Agents Pierre L. Triozzi, MD – Cleveland Clinic |
||
10:15 am - 10:50 am | Therapeutic Cancer Vaccines: Successes and Failures in the Clinic Joseph Baar, MD, PhD - Seidman Cancer Center |
||
10:50 am - 11:25 am | Adoptive T cell Transfer as an Anti-tumor Approach Gregory E. Plautz, MD – Cleveland Clinic |
||
11:25 am - 11:50 am | Panel Discussion | ||
11:50 am - 12:45 pm | Lunch | ||
12:45 pm - 1:20 pm | Therapeutic Checkpoint Blockade Brian I. Rini, MD – Cleveland Clinic |
||
1:20 pm - 1:55 pm | Rationale for Combining Immunotherapy with Chemotherapy or Targeted Therapy Qing Yi, MD, PhD - Cleveland Clinic |
||
1:55 pm - 2:30 pm | Immunotherapy: The Need for Immune Monitoring and Development of Predictive Markers Janis Taube, MD - Johns Hopkins School of Medicine |
||
2:30 pm - 2:55 pm | Panel Discussion | ||
2:55 pm - 3:00 pm | Closing Remarks |
All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.